Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors

BACKGROUND: Angiotensin receptor blockers (ARBs) and/or angiotensin-converting enzyme (ACE) inhibitors could alter mortality from coronavirus disease 2019 (COVID-19), but existing meta-analyses that combined crude and adjusted results may be confounded by the fact that comorbidities are more common...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Terry, Cau, Alessandro, Cheng, Matthew Pellan, Levin, Adeera, Lee, Todd C., Vinh, Donald C., Lamontagne, Francois, Singer, Joel, Walley, Keith R., Murthy, Srinivas, Patrick, David, Rewa, Oleksa G., Winston, Brent W., Marshall, John, Boyd, John, Tran, Karen, Kalil, Andre C., Mcculoh, Russell, Fowler, Robert, Luther, James M., Russell, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Systematic Review/Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023793/
https://www.ncbi.nlm.nih.gov/pubmed/33842874
http://dx.doi.org/10.1016/j.cjco.2021.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023793/
https://www.ncbi.nlm.nih.gov/pubmed/33842874
http://dx.doi.org/10.1016/j.cjco.2021.03.001

Ejemplares similares